ストックスクリーナーアプリを入手
354.06
4.84%
16.33
プレマーケット:
353.00
-1.06
-0.30%
前日終値:
$337.73
開ける：
$342.91
24時間の取引高:
4.73M
Relative Volume:
1.81
時価総額：
$191.09B
収益：
$37.30B
当期純損益:
$7.80B
株価収益率:
24.62
EPS:
14.3793
ネットキャッシュフロー:
$8.60B
1週間 パフォーマンス:
+2.45%
1か月 パフォーマンス:
+7.42%
6か月 パフォーマンス:
+11.56%
1年 パフォーマンス:
+21.33%
1日の値動き範囲:
$341.45
$358.46
1週間の範囲:
$337.49
$358.46
52週間の値動き範囲:
$267.83
$391.29
Amgen Inc Stock (AMGN) Company Profile
Compare AMGN vs LLY, JNJ, ABBV, MRK, NVS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
354.06 | 191.09B | 37.30B | 7.80B | 8.60B | 14.38 |
LLY
Lilly Eli Co
|
1,160.95 | 1.04T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
238.33 | 573.71B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
224.77 | 397.12B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
120.76 | 298.26B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
153.92 | 293.69B | 54.66B | 13.58B | 16.05B | 7.0171 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-21 | 開始されました | Canaccord Genuity | Hold |
| 2026-03-10 | 開始されました | Jefferies | Hold |
| 2026-02-20 | 開始されました | Barclays | Equal Weight |
| 2026-01-20 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | 再開されました | UBS | Buy |
| 2025-12-05 | アップグレード | Erste Group | Hold → Buy |
| 2025-11-24 | 再開されました | Truist | Hold |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-09-03 | 再開されました | Raymond James | Mkt Perform |
| 2025-05-20 | 再開されました | Guggenheim | Neutral |
| 2025-04-22 | 再開されました | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 再開されました | BofA Securities | Underperform |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-14 | 開始されました | Citigroup | Neutral |
| 2024-10-17 | 開始されました | Bernstein | Outperform |
| 2024-10-14 | ダウングレード | Truist | Buy → Hold |
| 2024-09-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-08-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-05-03 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 再開されました | Raymond James | Mkt Perform |
| 2024-02-07 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-11-02 | アップグレード | Truist | Hold → Buy |
| 2023-10-20 | 再開されました | JP Morgan | Neutral |
| 2023-10-17 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 再開されました | BofA Securities | Neutral |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2023-04-24 | 繰り返されました | Oppenheimer | Outperform |
| 2023-03-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 繰り返されました | Truist | Buy |
| 2022-11-18 | 開始されました | Credit Suisse | Underperform |
| 2022-10-31 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2022-10-11 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-02-09 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-09 | 繰り返されました | Jefferies | Buy |
| 2022-02-09 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 繰り返されました | Oppenheimer | Outperform |
| 2022-02-09 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Buy |
| 2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
| 2021-09-23 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 開始されました | Daiwa Securities | Buy |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-10-26 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | アップグレード | Truist | Hold → Buy |
| 2020-10-09 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | ダウングレード | Truist | Buy → Hold |
| 2020-10-08 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 再開されました | Guggenheim | Neutral |
| 2020-03-31 | 開始されました | Wolfe Research | Peer Perform |
| 2020-03-30 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 開始されました | Barclays | Equal Weight |
| 2020-01-31 | ダウングレード | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 開始されました | Raymond James | Mkt Perform |
| 2019-12-17 | 再開されました | Morgan Stanley | Overweight |
| 2019-11-12 | 開始されました | SunTrust | Buy |
| 2019-11-05 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 再開されました | BofA/Merrill | Neutral |
| 2019-08-19 | ダウングレード | Mizuho | Buy → Neutral |
| 2019-05-23 | アップグレード | Citigroup | Neutral → Buy |
すべてを表示
Amgen Inc (AMGN) 最新ニュース
Nuveen LLC Sells 86,287 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. Stock (US0311621009): Shares Jump On EU Cancer Drug Approval And New Trial Data - AD HOC NEWS
Amgen Inc. Stock (US0311621009): Dow component under pressure after recent pullback - AD HOC NEWS
Amgen taps research firm to reassess Tavneos data - Reuters
Amgen (AMGN) Faces FDA Scrutiny Over Tavneos Amid Safety Concerns - GuruFocus
A Look at Amgen Inc (AMGN) After 4.8% Gain -- GF Value $353.35 v - GuruFocus
Amgen hires Duke research organization to save Tavneos from market removal - Seeking Alpha
Amgen taps Duke Research Institute to reevaluate disputed Tavneos data - Investing.com
Amgen taps Duke Research Institute to reevaluate disputed Tavneos data By Investing.com - Investing.com Canada
Amgen’s Repatha Diabetes Data Reframes Cardiometabolic Upside For Investors - simplywall.st
Amgen Reevaluates Tavneos Data as Medicine Faces FDA Scrutiny - Bloomberg.com
Amgen Hires Avenue Solutions for Medicare Lobbying - Legis1
Amgen Named Among World’s Most Impactful Companies 2026 by TIME - Amgen
Amgen Inc. (AMGN) is attracting investor attention: Here is what you should know - MSN
Here is Why Amgen (AMGN) is One of the Top Large Cap Value Stocks to Buy Now - Insider Monkey
Dow's 750-Point Rally Led By Gains In Shares Of Amgen, Boeing - Moomoo
Amgen, Honeywell Share Gains Lead Dow's 265-Point Jump - Moomoo
Caterpillar, Amgen Share Gains Lead Dow's 414-Point Jump - 富途牛牛
Is Amgen Inc. (AMGN) A Good Stock To Buy Now? - Insider Monkey
Amgen Inc Stock (AMGN) Moved Up by 3.35% on Jun 11: What Signal Does It Send? - TradingKey
Dow Rallies 288 Points On Gains For Amgen, Caterpillar Shares - 富途牛牛
Renaissance Group LLC Has $36.95 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
J.Safra Asset Management Corp Takes Position in Amgen Inc. $AMGN - MarketBeat
Townsquare Capital LLC Sells 3,602 Shares of Amgen Inc. $AMGN - MarketBeat
Janney Montgomery Scott LLC Has $141.09 Million Stake in Amgen Inc. $AMGN - MarketBeat
ING Groep NV Buys New Shares in Amgen Inc. $AMGN - MarketBeat
Gilpin Wealth Management LLC Takes Position in Amgen Inc. $AMGN - MarketBeat
Capital Wealth Planning LLC Raises Position in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Amgen Can't Amend Petition To Address Potential Double Tax - Law360
Amgen Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
AMGN Maintains by Morgan Stanley -- Price Target Raised to $340 - GuruFocus
What Amgen CFO Told Goldman Sachs About the IRS, MariTide, and Why the Stock May Be Worth $467 - TIKR.com
Can Amgen's MariTide Win Share in the Fast-Growing Obesity Market? - Yahoo Finance
Motley Fool Asset Management LLC Increases Position in Amgen Inc. $AMGN - MarketBeat
Amgen eyes 2026 'springboard' as growth drugs offset patent pressure - MSN
Morgan Stanley raises Amgen stock price target on obesity drug potential - Investing.com Canada
Amgen Inc. stock (US0311621009): focus on weight-loss and cancer pipeline after latest earnings - AD HOC NEWS
Amgen Eyes 2026 ‘Springboard’ as Growth Drugs Offset Patent Pressure - MarketBeat
Amgen Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Is It Too Late To Consider Amgen (AMGN) After Its Strong Multi Year Share Price Run? - Yahoo Finance
Amgen Inc. $AMGN Shares Purchased by LPL Financial LLC - MarketBeat
Franklin Resources Inc. Has $712.09 Million Stake in Amgen Inc. $AMGN - MarketBeat
Cerity Partners LLC Has $134.82 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
AMGN|Amgen Inc|Price:349.076|Chg%:11.35 - TradingKey
Goldman Sachs Trims Amgen (AMGN) Valuation but Sticks with Buy Rating - Yahoo Finance
Amgen Inc. stock underperforms Monday when compared to competitors - MarketWatch
Amgen stock (US0311621009): FDA filing and pipeline momentum in focus - AD HOC NEWS
Why Amgen Inc (AMGN) Is Set to Outperform the Market: Insights i - GuruFocus
AMGN DCF Analysis: Intrinsic Value $292 vs Price $350 - GuruFocus
Can MariTide Save Amgen Stock From Its Fading Blockbusters? - Trefis
Amgen Inc (AMGN) 財務データ
収益
当期純利益
現金流量
EPS
2.69%
大文字化:
|
ボリューム (24 時間):